AMGEN LIMITED (02354269) is a private limited company registered in CAMBRIDGE, incorporated in 1989. The company operates in the research and experimental development on biotechnology sector. Our database holds 96 signals from 12 official sources covering this company's filings, appointments, and regulatory records. Risk assessment: 91/100 ("robust"), reflecting a strong compliance and financial profile.
AMGEN LIMITED is an active private limited company incorporated in 1989, located in Cambridge, specializing in research and experimental development on biotechnology, with 4 active officers.
Good data coverage from 12 sources. Risk score of 91 indicates a strong compliance profile.
AMGEN LIMITED is 1 of 301 research and experimental development on biotechnology companies in CAMBRIDGE, out of 4,035 active companies in this sector nationally (4,416 including dissolved).
The 3 directors of AMGEN LIMITED are connected to 9 other companies.
None of these connected companies have been dissolved.
AMGEN LIMITED is listed as the proprietor of 1 property in the HM Land Registry.
Properties are located in East Anglia.
AMGEN LIMITED has been awarded 4 government contracts with a combined value of £601.7M.
The most recent contract was with NHS England (12 Sept 2024).
AMGEN LIMITED has received 1 Innovate UK grant.
AMGEN LIMITED pays invoices in an average of 43 days. 46% are paid within 30 days.
This company profile is built from 12 official data sources: Ch Officers, Companies House, Contracts Finder, Environment Agency, Gateway to Research, Gender Pay Gap Service, HM Land Registry, HMRC Trade Info, ICO, Innovate UK, Payment Practices, WHOIS.
AMGEN LIMITED is an active private limited company incorporated in 1989, located in Cambridge, specializing in research and experimental development on biotechnology, with 4 active officers..
Current directors include MRS SOPHIE JANE HODGES, MR CHRISTOPHER PAUL WALKER, MR RUSSELL JAMES ABBERLEY and 1 more.
AMGEN LIMITED is registered in CAMBRIDGE, United Kingdom.
AMGEN LIMITED operates under SIC code 72110 — Research and experimental development on biotechnology.
AMGEN LIMITED has a risk score of 91 out of 100, classified as "Robust". This score is calculated from 96 data signals across 12 government sources.
The next accounts for AMGEN LIMITED are due on 30 Sept 2026.
Yes, AMGEN LIMITED is listed as the proprietor of 1 property in the HM Land Registry, located in East Anglia.
Yes, AMGEN LIMITED has been awarded 4 government contracts with a combined value of £601.7M.
The dissolution rate for the research and experimental development on biotechnology sector in the UK is 0.2%. The average company age in this sector is 7.1 years.
AMGEN LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
AMGEN LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
AMGEN LIMITED was incorporated on 1 Mar 1989, making it 37 years old. The company remains active and in good standing.
AMGEN LIMITED is classified under SIC code 72110 (Research and experimental development on biotechnology). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 96 data signals from 12 official government sources for AMGEN LIMITED.